Quinoxaline-1,4-dioxide Derivatives Inhibitory Action in Melanoma and Brain Tumor Cells

References

• Pereira JA Pessoa AM Cordeiro MNDS et al. Quinoxaline, its derivatives and applications: a state of the art review . Eur. J. Med. Chem.97 , 664 – 672 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Cheng G Sa W Cao C et al. Quinoxaline 1,4-di-N-oxides: biological activities and mechanisms of actions . Front. Pharmacol.7 ( MAR ), 64 ( 2016 ).
   PubMedGoogle Scholar
• Vicente E Villar R Pérez-Silanes S Aldana I Goldman RC Mong A . Quinoxaline 1,4-di-N-oxide and the potential for treating tuberculosis . Infect. Disord. Drug Targets11 ( 2 ), 196 – 204 ( 2011 ).
   PubMedGoogle Scholar
• Huang XJ Zhang HH Wang X et al. ROS mediated cytotoxicity of porcine adrenocortical cells induced by QdNOs derivatives in vitro . Chem. Biol. Interact.185 ( 3 ), 227 – 234 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Vieira M Pinheiro C Fernandes R Noronha JP Prudêncio C . Antimicrobial activity of quinoxaline 1,4-dioxide with 2- and 3-substituted derivatives . Microbiol. Res.169 ( 4 ), 287 – 293 ( 2014 ).
   PubMedGoogle Scholar
• Santivañez-Veliz M Pérez-Silanes S Torres E Moreno-Viguri E . Design and synthesis of novel quinoxaline derivatives as potential candidates for treatment of multidrug-resistant and latent tuberculosis . Bioorg. Med. Chem. Lett.26 ( 9 ), 2188 – 2193 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Al-Marhabi A Abbas H-A Ammar Y . Synthesis, characterization and biological evaluation of some quinoxaline derivatives: a promising and potent new class of antitumor and antimicrobial agents . Molecules20 ( 11 ), 19805 – 19822 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Gu W Wang S Jin X et al. Synthesis and evaluation of new quinoxaline derivatives of dehydroabietic acid as potential antitumor agents . Molecules22 ( 7 ), 1154 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Patel NB Patel JN Purohit AC et al. In vitro and in vivo assessment of newer quinoxaline–oxadiazole hybrids as antimicrobial and antiprotozoal agents . Int. J. Antimicrob. Agents50 ( 3 ), 413 – 418 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Miller E Xia Q Cella M et al. Voltammetric study of some 3-aryl-quinoxaline-2-carbonitrile 1,4-di-N-oxide derivatives with anti-tumor activities . Molecules22 ( 9 ), 1442 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Tariq S Alam O Amir M . Synthesis, anti-inflammatory, p38α MAP kinase inhibitory activities and molecular docking studies of quinoxaline derivatives containing triazole moiety . Bioorg. Chem.76 , 343 – 358 ( 2018 ).
   PubMed Web of Science ®Google Scholar
• Marzano C Pellei M Tisato F Santini C . Anti-cancer agents in medicinal chemistry . Anticancer Agents Med. Chem.9 ( 2 ), 185 – 211 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Liu Z-Y Sun Z-L . The metabolism of carbadox, olaquindox, mequindox, quinocetone and cyadox: an overview . Med. Chem.9 ( 8 ), 1017 – 1027 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• El Aissi R Liu J Besse S et al. Synthesis and biological evaluation of new quinoxaline derivatives of ICF01012 as melanoma-targeting probes . ACS Med. Chem. Lett.5 ( 5 ), 468 – 473 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Mielcke TR Mascarello A Filippi-Chiela E et al. Activity of novel quinoxaline-derived chalcones on in vitro glioma cell proliferation . Eur. J. Med. Chem.48 , 255 – 264 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Abbas H-AS Al-Marhabi AR Eissa SI Ammar YA . Molecular modeling studies and synthesis of novel quinoxaline derivatives with potential anticancer activity as inhibitors of c-Met kinase . Bioorg. Med. Chem.23 ( 20 ), 6560 – 6572 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Gao H Wang D Zhang S et al. Roles of ROS mediated oxidative stress and DNA damage in 3-methyl-2-quinoxalin benzenevinylketo-1, 4-dioxide-induced immunotoxicity of Sprague–Dawley rats . Regul. Toxicol. Pharmacol.73 ( 2 ), 587 – 594 ( 2014 ).
   Web of Science ®Google Scholar
• Ahmed HEA Ihmaid SK Omar AM et al. Design, synthesis, molecular docking of new lipophilic acetamide derivatives affording potential anticancer and antimicrobial agents . Bioorg. Chem.76 , 332 – 342 ( 2018 ).
   PubMed Web of Science ®Google Scholar
• Guo W Hao H Dai M et al. Development of quinoxaline 1, 4-dioxides resistance in escherichia coli and molecular change under resistance selection . PLoS ONE7 ( 8 ), e43322 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Pettersen EO Ebbesen P Gieling RG et al. Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: The METOXIA Consortium . J. Enzyme Inhib. Med. Chem.30 ( 5 ), 689 – 721 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Hanahan D Weinberg RA . Hallmarks of cancer: the next generation . Cell144 ( 5 ), 646 – 74 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Xu XD Shao SX Jiang HP et al. Warburg effect or reverse warburg effect? A review of cancer metabolism . Oncol. Res. Treat.38 ( 3 ), 117 – 122 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Mantovani A . Cancer: inflaming metastasis . Nature457 ( 7225 ), 36 – 37 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Ramli Y Moussaif A Karrouchi K Essassi EM . Pharmacological profile of quinoxalinone . J. Chem.2014 ( 563406 ), 1 – 21 ( 2014 ).
   Google Scholar
• Husain A Madhesia D . Recent advances in pharmacological activities of quinoxaline derivatives . J. Pharm. Res.4 ( 3 ), 924 – 929 ( 2011 ).
   Google Scholar
• Zhang M Dai ZC Qian SS et al. Design, synthesis, antifungal, and antioxidant activities of (E)-6-((2-phenylhydrazono)methyl)quinoxaline derivatives . J. Agric. Food Chem.62 ( 40 ), 9637 – 9643 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Moarbess G Deleuze-Masquefa C Bonnard V et al. In vitro and in vivo anti-tumoral activities of imidazo[1,2-a]quinoxaline, imidazo[1,5-a]quinoxaline, and pyrazolo[1,5-a]quinoxaline derivatives . Bioorganic Med. Chem.16 ( 13 ), 6601 – 6610 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Tseng C-H Chen Y-R Tzeng C-C et al. Discovery of indeno[1,2- b ]quinoxaline derivatives as potential anticancer agents . Eur. J. Med. Chem.108 , 258 – 273 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Deleuze-Masquefa C Moarbess G Khier S et al. New imidazo[1,2-a]quinoxaline derivatives: synthesis and in vitro activity against human melanoma . Eur. J. Med. Chem.44 ( 9 ), 3406 – 3411 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Khier S Deleuze-Masquéfa C Moarbess G et al. Pharmacology of EAPB0203, a novel imidazo[1,2-a]quinoxaline derivative with anti-tumoral activity on melanoma . Eur. J. Pharm. Sci.39 ( 1–3 ), 23 – 29 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Muz B de la Puente P Azab F Azab AK . The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy . Hypoxia (Auckl.)3 , 83 – 92 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Junnotula V Sarkar U Sinha S Gates KS . Initiation of DNA strand cleavage by 1,2,4-benzotriazine 1,4-dioxide antitumor agents: mechanistic insight from studies of 3-methyl-1,2,4-benzotriazine 1,4-dioxide . J. Am. Chem. Soc.131 ( 3 ), 1015 – 1024 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Garbe C Peris K Hauschild A et al. Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – update 2016 . Eur. J. Cancer63 ( 2 ), 201 – 217 ( 2016 ).
   PubMedGoogle Scholar
• Vartanian A Baryshnikova M Burova O et al. Inhibitor of vasculogenic mimicry restores sensitivity of resistant melanoma cells to DNA-damaging agents . Melanoma Res.27 ( 1 ), 8 – 16 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Aggarwal BB Vijayalekshmi RV Sung B . Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe . Clin. Cancer Res.15 ( 2 ), 425 – 430 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Hugo W Zaretsky JM Sun L et al. Genomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma . Cell165 ( 1 ), 35 – 44 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Urosevic-Maiwald M Barysch MJ Cheng PF et al. In vivo profiling reveals immunomodulatory effects of sorafenib and dacarbazine on melanoma . Oncoimmunology4 ( 2 ), e988458 ( 2015 ).
   PubMed Web of Science ®Google Scholar